Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SUJA
SUJA logo

SUJA Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
15.790
Open
15.510
VWAP
14.51
Vol
312.05K
Mkt Cap
595.98M
Low
13.755
Amount
4.53M
EV/EBITDA(TTM)
--
Total Shares
38.63M
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Suja Life, Inc. is a beverage platform. The Company operates at the intersection of health, taste, and trust, offering cold-pressed juices, wellness shots, and functional sodas that have become an essential part of consumers' everyday routines. Its brands include Suja Organic, Vive Organic, and Slice. Suja Organic is its flagship brand, known for its organic cold-pressed juices and wellness shots.it includes a green juice platform, boosted juice platform, refreshers platform, and wellness shots platform. Vive Organic is a wellness shot brand, known for the functional shot category with its doctor-crafted formulations and redefining how consumers approach proactive wellness. It offers an immunity boost platform, energy boost platform, and pure boost platform. Slice offers an original better-for-you soda, made with 10% real fruit juice and also with prebiotics, probiotics, postbiotics, reduced sugar, and no artificial ingredients.
Show More

Events Timeline

(ET)
2026-05-11
11:30:00
Mobia Medical, Odyssey Therapeutics and Others Go Public This Week
select
2026-05-07 (ET)
2026-05-07
12:30:00
Suja Life Prices 8.89M Shares at $21.00
select
2026-05-07
10:30:00
Suja Life Prices 8.89M Shares at $21.00
select

News

seekingalpha
8.5
06-01seekingalpha
PinnedSuja Life Receives Bullish Ratings After IPO Quiet Period
  • Wall Street Bullish Ratings: Suja Life (SUJA) received a clean sweep of bullish ratings from Wall Street after the IPO quiet period ended, with Goldman Sachs issuing a Buy rating and a price target of $31, reflecting strong market confidence in its growth potential.
  • New Growth Vector in Functional Beverages: Jefferies analyst noted that juice is being reframed around functional benefits and convenient formats, creating a new growth vector within a $19 billion category, positioning Suja Life favorably as distribution expands and multipacks grow.
  • Valuation Advantage: Gajrawala highlighted that Suja Life trades at a valuation of 13X the 2027 EBITDA estimate, which is a discount compared to high-growth peers, indicating its competitive edge and attractiveness in the market.
  • Strong Market Performance: Shares of Suja Life (SUJA) jumped 6.9% in premarket trading to $16.50, approaching the IPO price of $21, demonstrating investor optimism regarding its future development.
renaissancecapital
8.5
13:08 PMrenaissancecapital
May IPO Market Rebounds with $11.5 Billion Raised
  • Record Fundraising: Thirteen IPOs raised a total of $11.5 billion in May, marking the highest monthly proceeds since November 2021, indicating a robust market recovery and renewed investor confidence.
  • Large Deals Dominate: AI chipmaker Cerebras led the market with a $5.6 billion deal, while geothermal energy developer Fervo and data center REIT Blackstone Digital Infrastructure Trust also raised over $1 billion each, highlighting strong demand in AI-related sectors.
  • Strong IPO Performance: Traditional IPOs averaged a 5% return from their offer prices, with about half closing above their issue prices, reflecting positive market sentiment towards new listings, particularly with Fervo and BXDC showing strong first-day gains.
  • Optimistic Future Outlook: With new filings from companies like SpaceX, more IPO transactions are expected in the coming months as the market broadens, and strong returns alongside a solid pipeline set the stage for a busy IPO calendar ahead.
CNBC
6.0
06-01CNBC
Latest Rating Changes on Wall Street
  • Executive Rating Updates: Goldman Sachs initiates coverage on HawkEye 360 with a Buy rating, emphasizing its status as a profitable RF signals intelligence satellite operator, which is expected to achieve substantial revenue and earnings growth, reflecting strong confidence in its market potential.
  • Dell Rating Upgrade: Morgan Stanley upgrades Dell from Underweight to Equal Weight, admitting prior market expectations were incorrect, highlighting Dell's superior supply chain management and execution compared to peers, enabling effective capture of critical demand and market share gains.
  • MedTech Company Upgrade: Wells Fargo upgrades Tandem Diabetes Care to Overweight, citing an attractive risk/reward profile in the medical technology sector, indicating optimism about its future growth potential.
  • Microsoft Market Performance Initiation: Citizens initiates Microsoft with a Market Outperform rating and a $550 price target, reflecting strong market performance potential despite a 7% decline year-to-date, indicating resilience in its business model.
renaissancecapital
8.5
05-08renaissancecapital
Five IPOs and Three SPACs Priced This Week
  • HawkEye 360 IPO Performance: HawkEye 360 priced at the top of its range, raising $416 million with a market cap of $2.8 billion; despite being unprofitable, its strong revenue growth and increasing backlog indicate significant potential in the defense technology sector.
  • Odyssey Therapeutics Financing: Odyssey Therapeutics priced its upsized IPO at the top of the range, raising $279 million with a market cap of $911 million; although its stock fell 9%, the development of targeted therapies for autoimmune diseases suggests robust market demand.
  • Suja Life Market Challenges: Suja Life priced at the bottom of its range, raising $187 million with an $813 million market cap; despite leading in the cold-pressed juice market, a 15% decline in stock price highlights potential threats from shifting consumer preferences.
  • Rare Earths Americas IPO Success: Rare Earths Americas priced at the top of its range, raising $63 million with a market cap of $399 million; focusing on heavy rare earth elements, its stock rose 23% during the week, reflecting market confidence in its growth prospects.
renaissancecapital
8.5
05-07renaissancecapital
Suja Life Raises $187 Million in IPO at Low End of Range
  • Funding Size: Suja Life successfully raised $187 million by offering 8.9 million shares at $21 each, which is at the low end of the $21 to $24 range, indicating sustained market interest and demand for health-oriented beverages.
  • Product Portfolio: The company focuses on functional and health-oriented drinks, with brands including Suja Organic, Vive Organic, and Slice, offering cold-pressed juices, wellness shots, and functional sodas designed for various consumption occasions, enhancing its competitive edge in the market.
  • Production Capacity: Suja Life operates a vertically integrated cold-pressed beverage manufacturing facility in North America, ensuring high product quality and supply chain stability, thereby strengthening its position in the rapidly growing health beverage market.
  • IPO Details: Based in Oceanside, CA, Suja Life will trade on Nasdaq under the ticker SUJA, with joint bookrunners including Goldman Sachs, Jefferies, and William Blair, reflecting strong backing in the capital markets.
renaissancecapital
8.5
05-07renaissancecapital
Suja Life Plans $200 Million IPO for Health-Oriented Beverage Platform
  • IPO Fundraising Goal: Suja Life aims to raise $200 million by offering 8.9 million shares (2% secondary) at a price range of $21 to $24, intending to enhance its competitiveness in the health beverage market.
  • Product Diversification: The company offers cold-pressed juices, wellness shots, and functional sodas through its Suja Organic, Vive Organic, and Slice brands, catering to various consumption occasions and solidifying its market position in functional beverages.
  • Financial Performance: Suja Life reported $327 million in revenue for the 12 months ending December 31, 2025, indicating strong growth potential in the health beverage sector, with the IPO expected to provide funding for future expansion.
  • Listing Plans: Suja Life plans to price its IPO during the week of May 4, 2026, and list on Nasdaq under the ticker SUJA, which is anticipated to attract investor interest in the health beverage industry.
Wall Street analysts forecast SUJA stock price to rise
0 Analyst Rating
Wall Street analysts forecast SUJA stock price to rise
0 Buy
0 Hold
0 Sell
Current: 0.000
sliders
Low
Averages
High
Current: 0.000
sliders
Low
Averages
High
BofA
Neutral
initiated
$17
AI Analysis
2026-06-01
New
Reason
BofA
Price Target
$17
AI Analysis
2026-06-01
New
initiated
Neutral
Reason
BofA initiated coverage of Suja Life with a Neutral rating and $17 price target. Suja Life is a better-for-you beverage company focused on wellness shots, cold-pressed juices, and healthier soda alternatives, with growth tied to rising consumer demand for health, immunity, and energy benefits, the analyst tells investors in a research note. While a path exists to low-teens sales growth and attractive adjusted EBITDA margins through 2028, limited evidence of broad consumer adoption at scale and the potential for increasing commoditization temper the long-term outlook, the firm says.
Evercore ISI
Robert Ottenstein
initiated
$24
2026-06-01
New
Reason
Evercore ISI
Robert Ottenstein
Price Target
$24
2026-06-01
New
initiated
Reason
Evercore ISI analyst Robert Ottenstein initiated coverage of Suja Life with an Outperform rating and $24 price target. The company offers \"credible path\" to sustainable double-digit revenue growth and margin expansion, the analyst tells investors in a research note. The firm believes Suja Life has a \"large and growing\" market opportunity in a category with high barriers to scaled entry that is underpinned by favorable consumer trends.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SUJA
Unlock Now

Valuation Metrics

The current forward P/E ratio for Suja Life Inc (SUJA.O) is 0.00, compared to its 5-year average forward P/E of --. For a more detailed relative valuation and DCF analysis to assess Suja Life Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
Current PE
0.00
Overvalued PE
Undervalued PE

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
Undervalued EV/EBITDA

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
Current PS
0.00
Overvalued PS
Undervalued PS

Financials

AI Analysis
Annual
Quarterly

Whales Holding SUJA

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Suja Life Inc (SUJA) stock price today?

The current price of SUJA is 13.99 USD — it has decreased -9.33

What is Suja Life Inc (SUJA)'s business?

Suja Life, Inc. is a beverage platform. The Company operates at the intersection of health, taste, and trust, offering cold-pressed juices, wellness shots, and functional sodas that have become an essential part of consumers' everyday routines. Its brands include Suja Organic, Vive Organic, and Slice. Suja Organic is its flagship brand, known for its organic cold-pressed juices and wellness shots.it includes a green juice platform, boosted juice platform, refreshers platform, and wellness shots platform. Vive Organic is a wellness shot brand, known for the functional shot category with its doctor-crafted formulations and redefining how consumers approach proactive wellness. It offers an immunity boost platform, energy boost platform, and pure boost platform. Slice offers an original better-for-you soda, made with 10% real fruit juice and also with prebiotics, probiotics, postbiotics, reduced sugar, and no artificial ingredients.

What is the price predicton of SUJA Stock?

Wall Street analysts forecast SUJA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SUJA is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Suja Life Inc (SUJA)'s revenue for the last quarter?

Suja Life Inc revenue for the last quarter amounts to NaN USD, decreased

What is Suja Life Inc (SUJA)'s earnings per share (EPS) for the last quarter?

Suja Life Inc. EPS for the last quarter amounts to USD, decreased

How many employees does Suja Life Inc (SUJA). have?

Suja Life Inc (SUJA) has 0 emplpoyees as of June 02 2026.

What is Suja Life Inc (SUJA) market cap?

Today SUJA has the market capitalization of 595.98M USD.